Lymph Savior Official Website › Articles › Ingredient deep dive

Ingredient deep dive

Red Root: The Lymphatic Herb Whose Research Trail Stops In 1868

By the Lymph Savior Team at Lymphsaviior · Published 2026-09-20 · Revised September 30, 2026 · Reviewed by Dr. Carolyn Finnegan

The plant, and its reputation

Ceanothus americanus is a low North American shrub with white flower clusters and a deep red root. Its leaves were brewed as a tea substitute during the American colonial boycotts, which is where the name New Jersey tea comes from.

In Western herbal practice the root has a specific and long-standing role: it is the lymphatic remedy. It appears in nineteenth-century Eclectic materia medica, in twentieth-century herbals, and on a great many modern supplement labels sold for lymphatic support, including this one.

That reputation is the reason it is third on the Lymph Savior ingredient list. It is also, as far as the published literature goes, the whole of what is known about it.

What the medical index actually returns

Searching the National Library of Medicine for Ceanothus americanus, and for the same term alongside clinical, randomised and lymphatic keywords, returns a small and consistent set of results. None of them is a study in people of the root as a remedy.

That is the whole of it. No randomised trial, no controlled study, no pharmacokinetic work, no published safety series.

It is worth being precise about the claim being made here. This is not an assertion that the plant does nothing, and it is not a criticism of herbal practice, which has its own long traditions of observation. It is a statement about what has been published and indexed, which is close to nothing.

The one clinical record

The single indexed clinical article is D. L. Phares, writing in the Atlanta Medical and Surgical Journal, on Ceanothus americanus, red root, New Jersey tea (Phares, 1868).

It predates the randomised controlled trial by roughly eighty years, predates blinding, predates placebo control, and predates almost every method by which a modern reader would judge whether something worked. It is a physician writing down what he believed he had observed.

That is a legitimate historical document and it is a poor basis for spending money in 2026. It is cited here because it is the whole of the clinical record, and a reader is better served knowing that than being left to assume there is more.

Absence of evidence, and what it does and does not mean

The phrase absence of evidence is not evidence of absence gets used to close this conversation, and it deserves a more careful answer than that, because it is true and it is not a defence.

• It is true that no trial means no demonstrated effect, not a demonstrated lack of one. Red root may do something useful.
• It is also true that no trial means no demonstrated safety profile, no known dose, no known interactions and no idea what happens over months.
• A plant with two hundred years of traditional use has accumulated observation, and observation is worth something. It is not worth the same as a controlled comparison.
• The practical consequence is that nobody, including the manufacturer, can say what a useful amount of red root would be. And this label does not say how much it contains either.
• So two unknowns sit on top of each other: what the plant does, and how much of it is in the capsule.

Compare that with the horse chestnut two lines above it on the same label, where a specific extract at a specific dose was compared against compression stockings in 240 people (Diehm, Lancet 1996). The difference between those two ingredients is not a matter of degree. It is the difference between a number and a tradition.

Why a plant like this is on a modern label

Three reasons, and they are not all cynical.

The first is category signalling. Red root is what a lymphatic formula is expected to contain, in the same way a sleep formula is expected to contain valerian. Its presence tells a buyer familiar with the category that this is a lymphatic product.

The second is that herbal formulation has its own logic, in which plants are combined for traditional roles rather than assembled from trial data. That is a coherent system on its own terms even where it does not overlap with the evidence base.

The third is that it is cheap and uncontroversial. A plant with no trials also has no published adverse events, which is not the same as being safe but does make it easy to include.

The other five plants, ranked by what is known

Red root is the extreme case on this label, and the rest of the formula sits on a spectrum rather than at one end of it. Ranking the six by how much is actually known about them is a more useful exercise than reading the list in label order.

Read downward, the formula thins quickly. Two plants with dose-specific trials, two with trials in other conditions, one with three small studies in a different form, and one with none.

Nothing in that table is evidence about Lymph Savior, which has never been tested as a formula, and every amount in it belongs to a trial rather than to this bottle. It is a map of how much is known about each name on the label, which is the most a reader can have when the amounts are not published.

What a reader should do with it

1. Weigh the formula by its best-evidenced ingredient rather than by its longest list. On this label that is horse chestnut, followed by centella (Chong & Aziz, 2013).
2. Treat traditional ingredients as traditional. They may be doing something; there is no way to tell from outside and no way to dose them rationally.
3. Ask what a formula would look like without them. A six-plant capsule with two evidenced plants in it is, on the evidence, a two-plant capsule with four traditions attached.
4. Remember that no amount is published for any of the six here, which makes the question harder rather than easier.
5. If the traditional half of the formula is what appeals, that is a legitimate reason to buy it, and it is a different reason from the one the word research would suggest.

This article costs the product something and it is on the website that sells it. That is deliberate: a desk that only prints the parts of a label it likes is not describing a product, it is advertising one. The rest of the label is set out on the ingredients page, and the ladder is here.